•   
    2022 Corporate Webinars
    01:02:06
    Comprehensive Ophthalmology, Macular Disease, Retina/Vitreous, Vascular Disease

    In this corporate webinar sponsored by the Biosimilars Forum, a panel of experts discuss how the introduction of biosimilars will impact ophthalmological care, and policy proposals that would support adoption of ophthalmology biosimilars and the benefits they can bring to patients, providers, and the healthcare ecosystem. 

    Disclaimer: The webinar was sponsored by Biogen, but the speakers are solely responsible for the content. Any views expressed here represent only the views of the speakers.